These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1069 related articles for article (PubMed ID: 26276068)

  • 21. Effect of cardiac resynchronization therapy and implantable cardioverter defibrillator on quality of life in patients with heart failure: a meta-analysis.
    Chen S; Yin Y; Krucoff MW
    Europace; 2012 Nov; 14(11):1602-7. PubMed ID: 23104857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship Between Reverse Remodeling and Cardiopulmonary Exercise Capacity in Heart Failure Patients Undergoing Cardiac Resynchronization Therapy.
    Mastenbroek MH; Van't Sant J; Versteeg H; Cramer MJ; Doevendans PA; Pedersen SS; Meine M
    J Card Fail; 2016 May; 22(5):385-94. PubMed ID: 26363091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maximizing patient benefit from cardiac resynchronization therapy with the addition of structured exercise training: a randomized controlled study.
    Patwala AY; Woods PR; Sharp L; Goldspink DF; Tan LB; Wright DJ
    J Am Coll Cardiol; 2009 Jun; 53(25):2332-9. PubMed ID: 19539142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telemonitoring in heart failure patients treated by cardiac resynchronisation therapy with defibrillator (CRT-D): the TELECART Study.
    Sardu C; Santamaria M; Rizzo MR; Barbieri M; di Marino M; Paolisso G; Santulli G; Marfella R
    Int J Clin Pract; 2016 Jul; 70(7):569-76. PubMed ID: 27291327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of factors contributing to health related quality of life achieved with cardiac resynchronization therapy for heart failure.
    Van Hemel NM
    Minerva Cardioangiol; 2007 Dec; 55(6):783-802. PubMed ID: 18091646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of cardiac resynchronization therapy on hospitalizations in the Resynchronization-Defibrillation for Ambulatory Heart Failure trial.
    Gillis AM; Kerr CR; Philippon F; Newton G; Talajic M; Froeschl M; Froeschl S; Swiggum E; Yetisir E; Wells GA; Tang AS
    Circulation; 2014 May; 129(20):2021-30. PubMed ID: 24610807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.
    Zile MR; Abraham WT; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC
    Eur J Heart Fail; 2015 Oct; 17(10):1066-74. PubMed ID: 26011593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of multidisciplinary cardiac rehabilitation on the response to cardiac resynchronization therapy.
    Martens P; Jacobs G; Dupont M; Mullens W
    Cardiovasc Ther; 2018 Dec; 36(6):e12467. PubMed ID: 30239134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy on mortality and risk of defibrillator therapy for ventricular arrhythmias in heart failure patients (from the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region [STARTER] trial).
    Adelstein E; Alam MB; Schwartzman D; Jain S; Marek J; Gorcsan J; Saba S
    Am J Cardiol; 2014 May; 113(9):1518-22. PubMed ID: 24630387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial.
    Pouleur AC; Knappe D; Shah AM; Uno H; Bourgoun M; Foster E; McNitt S; Hall WJ; Zareba W; Goldenberg I; Moss AJ; Pfeffer MA; Solomon SD;
    Eur Heart J; 2011 Jul; 32(14):1720-9. PubMed ID: 21609974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac resynchronization therapy reduces T-wave alternans in patients with heart failure.
    Hua W; Chen K; Zhou X; Dai Y; Chen R; Wang J; Ding L; Liu Z; Feng T; Yu J; Cheng J; Liu C; Zhang S
    Europace; 2015 Feb; 17(2):281-8. PubMed ID: 25398405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cardiac resynchronization therapy: mortality, rehospitalization, and procedure-related complications. A three-year single-center observational study within the Italian Health System].
    Palmieri V; Pezzullo S; Coltorti F; Tavoletta V; Langella A; Scarnera P; Russo C; Celentano A
    G Ital Cardiol (Rome); 2012 May; 13(5):369-76. PubMed ID: 22539143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).
    Healey JS; Hohnloser SH; Exner DV; Birnie DH; Parkash R; Connolly SJ; Krahn AD; Simpson CS; Thibault B; Basta M; Philippon F; Dorian P; Nair GM; Sivakumaran S; Yetisir E; Wells GA; Tang AS;
    Circ Heart Fail; 2012 Sep; 5(5):566-70. PubMed ID: 22896584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac resynchronization therapy improves psycho-cognitive performance in patients with heart failure.
    Duncker D; Friedel K; König T; Schreyer H; Lüsebrink U; Duncker M; Oswald H; Klein G; Gardiwal A
    Europace; 2015 Sep; 17(9):1415-21. PubMed ID: 25745071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy. The Resynchronization for the HemodYnamic Treatment for Heart Failure Management II implantable cardioverter defibrillator (RHYTHM II ICD) study.
    Boriani G; Müller CP; Seidl KH; Grove R; Vogt J; Danschel W; Schuchert A; Djiane P; Biffi M; Becker T; Bailleul C; Trappe HJ;
    Am Heart J; 2006 May; 151(5):1050-8. PubMed ID: 16644335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.
    Lindenfeld J; Feldman AM; Saxon L; Boehmer J; Carson P; Ghali JK; Anand I; Singh S; Steinberg JS; Jaski B; DeMarco T; Mann D; Yong P; Galle E; Ecklund F; Bristow M
    Circulation; 2007 Jan; 115(2):204-12. PubMed ID: 17190867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of ventricular arrhythmias in patients with cardiac resynchronization therapy without back-up ICD: a single-center experience.
    Bortnik M; Degiovanni A; Dell'era G; Cavallino C; Occhetta E; Marino P
    J Cardiovasc Med (Hagerstown); 2014 Apr; 15(4):301-6. PubMed ID: 23811840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of mortality in patients undergoing cardiac resynchronization therapy: baseline clinical, echocardiographic, and angioscintigraphic evaluation prior to resynchronization.
    de Sisti A; Toussaint JF; Lavergne T; Ollitrault J; Abergel E; Paziaud O; Ait Said M; Sader R; LE Heuzey JY; Guize L
    Pacing Clin Electrophysiol; 2005 Dec; 28(12):1260-70. PubMed ID: 16403157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biventricular pacing improves quality of life and exercise tolerance in patients with heart failure and intraventricular conduction delay.
    Krahn AD; Snell L; Yee R; Finan J; Skanes AC; Klein GJ
    Can J Cardiol; 2002 Apr; 18(4):380-7. PubMed ID: 11992131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.